Home LiteratureArticle Details

PMID: 12794814 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.

Arthritis and rheumatism ·Vol. 48 ·No. 6 ·2003-06-00 ·Pages 1484-92

Silverman GJ, Weisman S

Abstract

暂无摘要

MeSH Terms

Animals Antibodies, Monoclonal/immunology,therapeutic use Antibodies, Monoclonal, Murine-Derived Arthritis, Rheumatoid/drug therapy,immunology Autoimmune Diseases/drug therapy,immunology B-Lymphocytes/drug effects Humans Lupus Erythematosus, Systemic/drug therapy,immunology Lymphoma, B-Cell/drug therapy,immunology Mice Purpura, Thrombocytopenic, Idiopathic/drug therapy,immunology Recombinant Fusion Proteins/immunology,therapeutic use Rituximab

Chemicals

Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Recombinant Fusion Proteins Rituximab

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Silverman Gregg J

Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0663, USA. gsilverman@ucsd.edu

Weisman Stuart

Article Info

Journal

Arthritis and rheumatism

Abbr.

Arthritis Rheum

ISSN

0004-3591

DOI

10.1002/art.10947

gsilverman@ucsd.edu

Published

2003-06-00

Pages

1484-92

Language

English

Region

United States

NLM ID

0370605

Subset

Grants

NIAID NIH HHS · AI-40305 · United States

NIAID NIH HHS · AI-46637 · United States

NIAMS NIH HHS · AR-47360 · United States

External Links

PubMed source DOI: 10.1002/art.10947 View journal details

Analysis Services

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.

Contact

WeChat Official Account